"12 (BigPharma/Biotech) companies, each worth >$35B, had 22 academic HC officers on their boards: med school deans, hosp presidents, HC dirs, dept chairs, division chiefs, high-level leaders. Avg pkg $475000, avg company stock holdings $1.7M"—Dr. Becker MD
https://twitter.com/dockaurG/status/1327272013317238784
November 10, 2020
Relationships Between Academic Medicine Leaders and Industry—Time for Another Look?
https://jamanetwork.com/journals/jama/fullarticle/2772764